Antiviral activity of salivary microRNAs for ophthalmic herpes zoster

Theoretical Biology and Medical Modelling

Volumn 9, Issue 1, 2012, Pages

  Irmak, M Kemal ^a   Erdem, Uzeyir ^a   Kubar, Ayhan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GEOCORIS; HERPES ZOSTER; HUMAN HERPESVIRUS 3;

ANTIVIRUS AGENT; MICRORNA;

ENDOCYTOSIS; GENE THERAPY; GENETICS; HERPES ZOSTER OPHTHALMICUS; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; REVIEW; SALIVA; VIROLOGY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; ENDOCYTOSIS; GENETIC THERAPY; HERPES ZOSTER OPHTHALMICUS; HUMANS; MICRORNAS; SALIVA; VIRUS REPLICATION;

EID: 84861879858     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-9-21     Document Type: Review

References (38)

1. Herpes zoster antivirals and pain management. Pavan-Langston D, Ophthalmol 2008 115 13 S20 10.1016/j.ophtha.2007.10.012 (Pubitemid 351173972)
2. Herpes zoster ophthalmicus. Karbassi M, Raizman MB, Schuman JS, Surv Ophthalmol 1992 36 395 410 10.1016/S0039-6257(05)80021-9 1589855
3. Evaluation and management of herpes zoster ophthalmicus. Shaikh S, Ta CN, Am Fam Physician 2002 66 1723 1730 12449270
4. Ophthalmic zoster. Marsh RJ, Br J Ophthalmol 1992 76 244 245 10.1136/bjo.76.4.244 1390496
5. Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster ophthalmicus. Wenkel H, Rummelt C, Rummelt V, Jahn G, Fleckenstein B, Naumann GO, Cornea 1993 12 131 317 10.1097/00003226-199303000- 00007 8388787
6. Directionality and further mapping of varicella zoster virus transcripts. Reinhold WC, Straus SE, Ostrove JM, Virus Res 1988 9 249 261 10.1016/0168-1702(88)90034-2 2833048 (Pubitemid 18052500)
7. Varicella-zoster virus. Cohen JI, Straus SE, Arvin AM, Fields Virology Lippincott Williams & Wilkins, Philadelphia, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, 5 2007 2773 2818
8. RNA-based gene delivery system hidden in breast milk microvesicles. Irmak MK, Oztas Y, Oztas E, J Exp Integr Med 2012 2 125 136
9. Exosomes from human saliva as a source of microRNA biomarkers. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, Illei GG, Alevizos I, Oral Dis 2010 16 34 38 10.1111/j.1601-0825.2009.01604.x 19627513
10. Proteomic analysis of two types of exosomes in human whole saliva. Ogawa Y, Miura Y, Harazono A, Kanai-Azuma M, Akimoto Y, Kawakami H, Yamaguchi T, Toda T, Endo T, Tsubuki M, Yanoshita R, Biol Pharm Bull 2011 34 13 23 10.1248/bpb.34.13 21212511
11. MicroRNA therapeutics. Broderick JA, Zamore PD, Gene Ther 2011 18 1104 1110 10.1038/gt.2011.50 21525952
12. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 215 233 10.1016/j.cell.2009.01.002 19167326
13. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Umbach JL, Cullen BR, Genes Dev 2009 23 1151 1164 10.1101/gad.1793309 19451215
14. A cellular microRNA mediates antiviral defense in human cells. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Sab A, Voinnet O, Science 2005 308 557 560 10.1126/science.1108784 15845854 (Pubitemid 40570587)
15. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M, Science 2007 315 1579 1582 10.1126/science.1136319 17322031 (Pubitemid 46449475)
16. Changes in microRNA expression profiles in HIV-1-transfected human cells. Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, Jeang KT, Retrovirology 2005 28 2 81
17. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F, Boshoff C, Nat Cell Biol 2010 12 513 519 10.1038/ncb2054 20418869
18. MiR-101 regulates HSV-1 replication by targeting ATP5B. Zheng SQ, Li YX, Zhang Y, Li X, Tang H, Antiviral Res 2011 89 219 226 10.1016/j.antiviral.2011. 01.008 21291913
19. Gene therapy for diseases of the cornea-a review. Williams KA, Coster DJ, Clin Experiment Ophthalmol 2010 38 93 103 19958372
20. Gene therapy in the Cornea: 2005-present. Mohan RR, Tovey JC, Sharma A, Tandon A, Prog Retin Eye Res 2011 31 43 64 21967960
21. An antiviral small-interfering RNA simultaneously effective against the most prevalent enteroviruses causing acute hemorrhagic conjunctivitis. Jun EJ, Won MA, Ahn J, Ko A, Moon H, Tchah H, Kim YK, Lee H, Invest Ophthalmol Vis Sci 2011 52 58 63 10.1167/iovs.09-5051 20739472
22. Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters. Tong YC, Chang SF, Liu CY, Kao WW, Huang CH, Liaw J, J Gene Med 2007 9 956 966 10.1002/jgm.1093 17724775 (Pubitemid 350104410)
23. Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells. Contreras-Ruiz L, de la Fuente M, Párraga JE, Lápez-García A, Fernández I, Seijo B, Sánchez A, Calonge M, Diebold Y, Mol Vis 2011 17 279 290 21283563
24. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VH, Pharm Res 2004 21 641 648 15139521 (Pubitemid 38457287)
25. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR, J Proteome Res 2009 8 1304 1314 10.1021/pr800658c 19199708
26. rab5 controls early endosome fusion in vitro. Gorvel JP, Chavrier P, Zerial M, Gruenberg J, Cell 1991 64 915 925 10.1016/0092-8674(91)90316-Q 1900457 (Pubitemid 121001179)
27. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M, Cell 1992 70 715 728 10.1016/0092-8674(92)90306-W 1516130
28. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. Sharma S, Rasool HI, Palanisamy V, Mathisen C, Schmidt M, Wong DT, Gimzewski JK, ACS Nano 2010 4 1921 1926 10.1021/nn901824n 20218655
29. Cellular endocytosis and gene delivery. Ziello JE, Huang Y, Jovin IS, Mol Med 2010 16 222 229 20454523
30. Adenovirus: a blueprint for non-viral gene delivery. Chailertvanitkul VA, Pouton CW, Curr Opin Biotechnol 2010 21 627 632 10.1016/j.copbio.2010.06.011 20638266
31. Adenovirus structure. Rux JJ, Burnett RM, Hum Gene Ther 2004 15 1167 1176 10.1089/hum.2004.15.1167 15684694 (Pubitemid 40052430)
32. Endocytosis of adenovirus and adenovirus capsid proteins. Medina-Kauwe LK, Ad Drug Deliv Rev 2003 55 1485 1496 10.1016/j.addr.2003.07.010 (Pubitemid 37464574)
33. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, Hemmi S, Greber UF, J Cell Biol 2002 158 1119 1131 10.1083/jcb.200112067 12221069
34. Virus-mediated release of endosomal content in vitro: different behaviour of adenovirus and rhinovirus serotype 2. Prchla E, Plank C, Wagner E, Blaas D, Fuchs R, J Cell Biol 1995 131 111 123 10.1083/jcb.131.1.111 7559769
35. Adenovirus endocytosis. Meier O, Greber UF, J Gene Med 2004 6 152 S163 10.1002/jgm.553 14978758 (Pubitemid 40228024)
36. The role of protein secretion systems in the virulence of the intracellular pathogen Legionella pneumophila. De Buck E, Anne J, Lammertyn E, Microbiology 2007 153 3948 3953 10.1099/mic.0.2007/012039-0 18048909
37. Infectious adenovirus type 2 transport through early but not late endosomes. Gastaldelli M, Imelli N, Boucke K, Amstutz B, Meier O, Greber UF, Traffic 2008 9 2265 2278 10.1111/j.1600-0854.2008.00835.x 18980614
38. Proceeded diagnosis and therapy in eye diseases under the light of developments in molecular biology and genetics. Guran S, Gulhane Med J 2011 53 74 76